its going to drop right before the news, spike if the news is good then sell off again from all the people who have been holding for that particular event?
what are you expecting, just curious?
thanks for your grand insight. lol
thanks for calling me those names, hope you feel big. thx. lolol anyway lol
But the boards can be used a lot better than the blogs and seeking alpha misinformed articles that are written by people looking for attention to get paid by clicks.
it all depends on the people willing to post on a board.
But yes, on many of the yahoo boards its filled with retail that don't have a clue, or they’re scared out of their minds into what they got themselves into or actually just want to talk about stocks they own with other people that care about their investments lolol surprise, surprise.
With this new influx of interest into cytr I was hoping for people who actually cared about what they held but this group is no better than the negative group that got wrecked from the 2012 summer pump then the fall offering, I had to deal with.
I was referring to you posting that you believe imuc management has some special knowledge about the results of this ph 2, not accurate, as far as they go 107 is a winner long ago but this trial will give us a better idea. I really got lost in this secondary reply.
This other statement of yours ”If the Phase II results for ICT-107 are not strong, there is no company and they won't be able to advance their other drugs.” This is totally inaccurate as the other drugs are not the same as 107.
yep you got me straight on lol now lets talk about cytr, which many of you arent ready to do.
I dont care about this kiddy name calling or your silly little up or down ratings, just whats going on with stocks i have an interest in and to tell you the truth, I've been here a year and it was only the negative people that i had to deal with until those seeking alpha articles came and now its all pump, and both didn't have a clue.
So when anyone wants to talk about this stock im here. I refuse to lower myself to name calling, or childish derogatory remarks. It doesn't move the conversation along and its a waste of time.
if you have a problem with what i wrote just say "i think you're wrong because XYZ and call it a day. i'm not going to take you seriously otherwise.
This is not accurate.
1) Dr Yu and company strongly believes in 107. Their minds were made up long ago and not based on whatever comes of this recent trial.
2)On the last call Yu said they were going forward with seeking someone with the manufacturing they need someone to produce the other drugs for the other upcoming trials. That wasn’t a surprise as who were they going with? Surprise, surprise someone they already have a relationship with.
research outside of the Seeking Alpha nonsense articles. Regardless of whether you have a negative attitude or positive attitude on this stock, a lot of you have not done the necessary research.
i've been watching scott file for the last year and half that i've been following or in this stock, you brought up scott peterson, so who is he? just answer the question.
lolol thx for the aapl tip lollol but lets get back to CYTR and what management is doing with our shareholder money. good luck.
just put the multiple posters on ignore. Flashywildwest and a lot of these people with the 5 posts in an hour or whatever over nothing like daily price swings, just ignore em.
And this is what I mean by not having a feel for the company, I suggest you look at the SEC filings to see what management is making, its high and the ceo is banking on these offerings. It might be me but this guy and management is taking too much to fill his own pockets at shareholder expense and the board is all of his buddies, so I’m not a big fan of management although I once was.
And if I’m not mistaken the compensation is setup like many of these microcaps where management gets compensation hitting certain milestones ie management can justify pay increases by starting and doing all these trials which I say again is starting to look like a racket. They started with a focus with aldoxorubicin for starting soft tissue sarcoma and now they’re doing all this other stuff. So instead of just focusing on that and reserving money, management will keep coming back to shareholders for dilutions to fund these other trials for this 1 drug.
If the STS trial works out then the company can easily pay for all these other trials with earnings instead of killing shareholders. It just doesn’t add up to me.
I’m frustrated with management with what they’ve done since stopping Tamibarotene.
I was one of the very few positive people on this board before the recent pumping Alpha articles came out but these posts show me you don't have a feel for this company. Its like you just found this on a screener.
I entered Cytr because the momentum had taken all life out of it with that late 2012 offering so it was at the bottom of the price range. The same thing has happened again from this last offering, 2.25 seems to be the bottom and we see what will happen to the share price.
Now I told people to watch out for the strong price swings of this stock and there were going to be better opportunities to jump in here and nobody listened, then the offering came, so whatever.
I was wrong about the ceo and didn’t examine cytr’s management and one of the bears on this board mrshashaberry? (I don’t know something like that) tried pointing this out to me but I didn’t listen because that user would rant about negative nonsense that I actually took the time to disprove but it seems they were right about the ceo and management.
or $1 lolol
do you really have all of your money in this? you know the ceo has done an offering at least the last 2 years and he and his friends have scalped nearly 10% of both stock offerings to fill their pockets?
its really starting to look like a racket to me, especially with all the hype and trying the drug on this disease and that disease. how about focusing on 1 disease and stop with the other stuff? its a racket. I didn't believe it at first but i dont see another way. hopefully this works out and im totally wrong but they are depleting the coffers with not having the drug nowhere near coming before the FDA.
I’d like to see what happens when the volume gets to a normal range. Im speculating the great price swing is from Cantor unloading shares but there is still demand out there for shares because IMUC rebounds. I’d like to see what happens to the share price when whoever it is stops dumping shares and see what the new price range is..
lolololol no good news for you if history repeats itself. look at a ytd chart and look at key events.